CBG crystal resistant distillate for flowable high-minor formulations.

CBG CRD from Cilo Cybin's GMP cannabinoid API portfolio: 20-40% CBG with 17%+ minor cannabinoids, low-viscosity golden oil, and formulation-ready documentation.

This page provides supporting information about Cilo Cybin's company platform, products, services, and stakeholder communications.

A CBG-led broad spectrum distillate designed to preserve flowability while carrying a meaningful minor cannabinoid profile.

CBG CRD is a crystal resistant CBG distillate designed to maintain low viscosity and support extended flowability in oil-soluble product systems. The target profile is 20-40% CBG with ≥17% minor cannabinoids and a ≤0.3% THC target.

Use CBG CRD when a formulation needs a CBG-led oil input with easier handling than a powder and a broader minor cannabinoid profile. Use CBG Isolate when the program requires a high-purity CBG powder with tighter single-cannabinoid dose control.

Use these pages to move between adjacent products without losing the family context.

Send the Cilo Cybin team your target format, desired specification, estimated volume, destination market, and documentation requirements.

Pharmaceutical biotechnology for regulated cannabinoid API's, bulk products, finished formats, and partner supply programs.

For partnership, product, or company enquiries, contact Cilo Cybin for the latest approved information.